The Boehringer Ingelheim and Lilly Alliance leverages the strengths of two of the world’s leading pharmaceutical companies. By joining forces, the companies demonstrate their commitment, not only to the care of people with type 2 diabetes, but also to address areas of unmet medical need like heart failure and chronic kidney disease. We from the Boehringer Ingelheim and Lilly Alliance proudly support World Kidney Day and its mission to improve kidney health for all. Learn more at

Follow Boehringer Ingelheim on TwitterFacebookLinkedIn and Instagram